Patents by Inventor Mikiya Miyazato

Mikiya Miyazato has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Peptide or pharmaceutically acceptable salt thereof, or prodrug thereof
    Patent number: 10550153
    Abstract: To provide a peptide that selectively activates type 2 neuromedin U receptor and is chemically stable under physiological conditions. A peptide represented by Formula (1) described in the specification.
    Type: Grant
    Filed: January 19, 2018
    Date of Patent: February 4, 2020
    Assignees: TOKYO UNIVERSITY OF PHARMACY & LIFE SCIENCES, NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER, KYOTO PHARMACEUTICAL UNIVERSITY
    Inventors: Yoshio Hayashi, Kentaro Takayama, Mikiya Miyazato, Kenji Kangawa, Kenji Mori, Akira Yamamoto, Toshiyasu Sakane
  • PEPTIDE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, OR PRODRUG THEREOF
    Publication number: 20190359652
    Abstract: To provide a peptide that selectively activates type 2 neuromedin U receptor and is chemically stable under physiological conditions. A peptide represented by Formula (1) described in the specification.
    Type: Application
    Filed: January 19, 2018
    Publication date: November 28, 2019
    Inventors: Yoshio HAYASHI, Kentaro TAKAYAMA, Mikiya MIYAZATO, Kenji KANGAWA, Kenji MORI, Akira YAMAMOTO, Toshiyasu SAKANE
  • Polypeptide and the use thereof
    Patent number: 7943580
    Abstract: The present invention provides a variety of useful polypeptides. In particular, a polypeptide comprising the same or substantially the same amino acid sequence as the amino acid sequence represented by SEQ ID NO: 1, SEQ ID NO: 2 or SEQ ID NO: 3, its amide, or a salt thereof can be used as an agent for preventing/treating hypotension; an agent for preventing/treating obesity, hyperphagia, etc.; an agent for preventing/treating lethargy, time-zone change syndrome (jet lag), etc.; an agent for preventing/treating sterility, etc. A compound or its salt that promotes the activity of a polypeptide comprising the same or substantially the same amino acid sequence as the amino acid sequence represented by any of SEQ ID NOS: 7 to 12 and 37 to 42, its partial peptide, or a salt thereof is useful as an agent for preventing/treating, e.g., menopausal symptoms or hyperthyroidism. A compound or its salt that inhibits the activity of said polypeptide is useful as an agent for preventing/treating, e.g.
    Type: Grant
    Filed: December 22, 2005
    Date of Patent: May 17, 2011
    Assignees: National Cerebral and Cardiovascular Center, Takeda Pharmaceutical Company Limited
    Inventors: Kenji Kangawa, Kenji Mori, Mikiya Miyazato, Masayasu Kojima
  • Novel Polypeptide and the Use Thereof
    Publication number: 20080124335
    Abstract: The present invention provides a variety of useful polypeptides. In particular, a polypeptide comprising the same or substantially the same amino acid sequence as the amino acid sequence represented by SEQ ID NO: 1, SEQ ID NO: 2 or SEQ ID NO: 3, its amide, or a salt thereof can be used as an agent for preventing/treating hypotension; an agent for preventing/treating obesity, hyperphagia, etc.; an agent for preventing/treating lethargy, time-zone change syndrome (jet lag), etc.; an agent for preventing/treating sterility, etc. A compound or its salt that promotes the activity of a polypeptide comprising the same or substantially the same amino acid sequence as the amino acid sequence represented by any of SEQ ID NOS: 7 to 12 and 37 to 42, its partial peptide, or a salt thereof is useful as an agent for preventing/treating, e.g., menopausal symptoms or hyperthyroidism. A compound or its salt that inhibits the activity of said polypeptide is useful as an agent for preventing/treating, e.g.
    Type: Application
    Filed: December 22, 2005
    Publication date: May 29, 2008
    Inventors: Kenji Kangawa, Kenji Mori, Mikiya Miyazato, Masayasu Kojima